Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I dont understand, sorry, what do you think is happening to cause the pps rise?
SCINENTIFIC AMERICAN
Authentic Drugs Tagged with Plant DNA Could Help Snare Fake Meds
http://www.scientificamerican.com/article/authentic-drugs-tagged-with-plant-dna-could-help-snare-fake-meds/
Im back in a 2.64, maybe i should've waited for lower?
Zacks has been completely wrong in their APDN predictions for years. They have 0 credibility as far as I am concerned.
This is mostly correct. The original question gives me the impression that there is a misunderstanding of exactly what DNA and a "hard drive" are fundamentally (no offense intended). Comparing DNA to a "hard drive" (of which there are different types of hard-drives, which work on different technologies) is purely symbolic for purposes of illustrating a high level point. DNA is "like" a hard drive in that they both store information. You could also say DNA is like a safe, or like a box, in that you also use those to store things. That is really where the similarities end.
I'm back in @ $2.85, just wanted to say hi to the old gang AND HAPPY THANKSGIVING!
Applied DNA Sciences’s “Buy” Rating Reaffirmed at Maxim Group (APDN)
http://www.wkrb13.com/markets/880313/applied-dna-sciencess-buy-rating-reaffirmed-at-maxim-group-apdn/
Read the article published today, and draw a conclusion based on that combined with the research and the critical thinking you've done to get you in the position you're now in. But seek first his kingdom and his righteousness, and all these things will be given to you as well. Sounds like you cant lose either way!
https://media4.giphy.com/media/5eM4x8fxZNzPO/giphy.gif
There is nothing in the article (at least what is available free online) that wasn't already discussed in depth on this board. The only exception being the happenings before Hayward acquired the company, which isn't even relevant. Maybe this article will ruin the company, but if it does it's not because they're exposing some conspiracy.
Well that was a wild afternoon. Anyway, back in under $3!
I've said that ill keep some of my original profits involved with APDN until bust or the moon, lets see how this plays out!
Market Cap is still too high I think. Too many potential revenue streams vs. actual revenue right now to justify ~$120M Market Cap. Just my opinion. I'm looking to start buying again at lower prices over the next couple of months.
Keep in mind the tax implications of flipping like that, i got burned a couple of years ago by not accounting for that.
Sorry to sound like a broken record, but since there was no actual revenue tied to any of the PRs recently released, i don't see why we wouldn't retrace back to $3 or below. This seems like just another pump & dump. I sold half of my position at $6. I did well this round since my last entry point was at $2.50 (see my previous post on 6/26/2015). Ill be looking to buy back shares around $3 this time. I hope I'm wrong, and I think still think this company has REAL potential, but I've seen this happen so many times already. GLTA!
I didn't mean to make a political statement just that this tech could've been used in a positive way to catch criminals.
This would've actually been really useful during the recent rioting in Baltimore. Many of the CVS and Rite Aid pharmacies were targeted during the rioting and narcotics were stolen specifically. The DNA fog could've helped to identify all involved parties.
Sub $2 would place the pre-split price at or under $.03. I don't remember the pps falling below $.04 even back before 2011. Does getting that low put the company in danger of bankruptcy? Apologies if that is a silly question.
The pps ranged from $2.40 to $2.70 for 2 months leading up to last week's surge to the upper $3 range. My non-expert opinion is that it would be better to wait until it returns to the mid $2 range before jumping back in. My guess is it will take a month for it to step back down. Just my guess based on prior behavior of this stock.
I don't mean to be argumentative. This is the last post I'm allowed for today. User dogturdcannon listed all of the sites that were pumping apdn last week (pasted from his comment below). I didn't mean to imply that the official apdn PRs were marketing the pump n' dump
APPLIED DNA SCIENCES INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
EDGAR Online Thu Jun 18 2015
11:02 am Applied DNA Sciences partnered with the Fairfield (NJ) Police Department to create the first 'DNA Protected Community' in New Jersey
Briefing.com Thu Jun 18 2015
Applied DNA Sciences Partners with Fairfield (NJ) Police Department to Create State's First DNA-Protected Community
Marketwired Thu Jun 18 2015
Applied DNA Sciences' DNA Home Asset Marking Program Promoted at Camden County, NJ News Conference
Marketwired Wed Jun 17 2015
Applied DNA Sciences Signs Agreement With Louis Dreyfus Commodities to Secure Global Cotton Logistic Supply Chain Through SigNature(R) T Botanical DNA-Tagging
Marketwired Tue Jun 16 2015
Butler Evergreen Teams Up With Applied DNA Sciences to Ensure Highly Secure Supply Chain, Including Production, Distribution and Dispensing Locations
I think the market will only truly respond to specific revenue in dollars. What is the specific amount of annual reoccurring revenue that will be generated by last week's PR's? When we know that, the market will respond, not just pump and dump schemes.
This is the dumpers dumping from last week's pump. At this point it seems very straight forward to me. Mcsharky was calling it. Its been the same pattern even before the split. I imagine this will continue to happen as long as this stock is able to be manipulated. I see no tangible reason for last weeks rise. We don't know what the cotton contract is worth, or how much it will cost to fulfill that contract. The pps rose because there were micro cap newsletters going out promoting the stock. Unless we get a juicy PR, I assume the pps will just walk back down and approach $2. Im no expert so don't take my advice, but ill buy more shares if we get back down under $2.40 and ill sell off again on the next pump. Ive been in this one for so long, now I'm just rotating shares I've owned for over 1 year to ride each pump, and sell them for a profit with a better tax implications. Rinse repeat.
Settings-->General-->Keyboard-->Turn Off Auto-Correction
Well Today I Learned...
Actress Julia Louis-Dreyfus (SNL, Seinfeld) is the great great grand daughtor of Léopold Louis-Dreyfus, who in 1851 founded the Louis Dreyfus Group, a French commodities and shipping conglomerate, which members of the family control to this day. He rapidly diversified across shipping, weapons manufacturing, agriculture, oil and banking, thus establishing one of the wealthiest dynasties in Europe.By the early 20th century, the Louis-Dreyfus family was described as one of the "five great fortunes of France". The company is worth $63.6 Billion as of 2013
Any idea what this is worth to APDN?
Heck yea I remember, I was one of the lucky ones that sold off ~2/3rds of my position at .29
Id be cursing the world if I'd missed that. I really feel bad for some of the other posters on this board, a lot of people lost a lot of money in-between now and then.
There has been so much hype in the past several years, the fact is that the PPS today is right where it was ~5 years ago.
They should talk about how their pre-split PPS is currently sitting around $.04, the same level it was at prior to the initial excitement from the DLA pilot 5 years ago.
This is going to draw the attention of newsletters after close today. Should be an interesting lead up to the next financial release. Might be a good idea to cash out before financials, then get back in after.
Fool me once...
"APDN is currently involved in a trial with one of the world's largest pharmaceutic companies."
Was this publicly known info before today?
Well I said I'd consider coming back if we're in the $2's, so here I am. Ready to give it another go around!
Ah that's what's great about the interwebs: One can go back to old comments to see who had it right and who was full of BS. Sea Pigeon, looks like you nailed this one. I love going back and checking everyone's old posts to see who is worth paying attention to, based on previous track records.. It's great for following politics too. It seems like everyone has short, selective memories these days. I'm still hoping to get back in under $2, but I'm severing all emotional ties I may have had with this company, that's a death sentence.
Hi All,
I must bid everyone fond farewell for now!
I've stuck it out as long as I could, I'm standing by what I wrote in Q414, if we don't have any substance(serious revenue vs expenses) by the first report of 2015, I'm selling off, so I did yesterday morning.
The average price of my remaining shares was .067, so selling off at $4 post split, at least able to get back what I paid (in 2011!bla). I did make out on the run to $.30, so I can't complain. I also enjoyed watching this company grow, and will continue to do so. Maybe I'll see ya'll again if we get into the $2 range, I'll leave this money in my brokerage account and maybe I'll try my hand at playing the swings. Good luck everyone, I'll be watching from the sidelines for now. Kbar out -
Zachs has been consistently wrong on their APDN predictions for at least 2 solid years. Haven't they been predicting $15 ($0.25 per split), since 2012? As a great man once said:
"There's an old saying in Tennessee - I know it's in Texas, probably in Tennessee - that says, fool me once, shame on - shame on you. Fool me - you can't get fooled again".
This is BS. It's a half-ass effort from the original scope of the DLA pilot. This does nothing to address counterfeits entering the supply chain. Just another disappointment from the govt and APDN.
Yea it's hard to take them seriously when they've confidently and consistently predicted APDN to be at $.25 ($15 adjusted for reverse split) for the past 2+ years
This story is trending on reddit, the top comments are taking about APDN
http://www.reddit.com/r/todayilearned/comments/2phjax/til_dna_testing_showed_that_one_in_three_fish/
One In Three Fish Sold At Restaurants And Grocery Stores Is Mislabeled
http://www.npr.org/blogs/thesalt/2013/02/21/172589997/one-in-three-fish-sold-at-restaurants-and-grocery-stores-is-mislabeled
I wonder how that Nissha contract is working out.
I think this technology will be great and I'm hoping for the best I know I've been in this for a while and I am hoping for great things because this technology is not just for one area it is for many different thing from medical two cars the military so many business can benefit from its technology even clothing medicine we just need the right timing and the right people to make it happen and I do believe it can and will.
This might be the best run on sentence I've ever read. Is this a bot? This belongs on reddit.
Estamos assistindo você , Doutor Hayward
Applied DNA Sciences
PRESS RELEASE
November 20, 2014
For Immediate Release
Contact:
Media Relations
631-240-8800
Applied DNA Sciences
Applied DNA Sciences Inc. Announces Closing of $9.1 Million Underwritten Offering
Stony Brook, NY. November 20, 2014. Applied DNA Sciences, Inc.(NASDAQ: APDN) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication, announced the closing of an underwritten public offering of 2,800,000 shares of common stock, and warrants to purchase up to an aggregate of 2,800,000 shares of common stock, at an offering price of $3.24 per share and $0.01 per warrant. The warrants have a per share exercise price of $3.50, are exercisable immediately, and expire five years from the date of issuance. The gross proceeds to Applied DNA Sciences from this offering are approximately $9.1 million before deducting the underwriting discount and other offering expenses. The Company has granted the underwriters a 45-day option to purchase up to an aggregate of 420,000 additional shares of common stock and/or up to 420,000 additional warrants to cover over-allotments, if any.
Maxim Group LLC acted as the Sole Book Running Manager with Dawson James Securities acted as co-manager in the offering.
The Company intends to use the net proceeds from the offering to fund working capital, repurchase of warrants, business development and research and development.
The Company's common stock and warrants began trading on the NASDAQ Stock Market LLC on November 17, 2014 under the symbols APDN and APDNW, respectively.
A registration statement on Form S-1 relating to these securities was declared effective by the Securities and Exchange Commission on November 14, 2014. The offering of these securities was made only by means of a written prospectus forming part of the registration statement. Copies of the final prospectus relating to this offering may be obtained from Maxim Group LLC, 405 Lexington Avenue, 2nd Floor, New York, NY 10174 or via telephone at 212-895-3745. The final prospectus relating to the offering is also available on the SEC's website at http://www.sec.gov.
This press release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About Applied DNA Sciences
Applied DNA Sciences (APDN) is a provider of botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA describes the uncopyable marker that is at the heart of all of our security and authentication solutions. SigNature DNA is at the core of a family of products such as DNAnet®, our anti-theft product, SigNature® T, targeted toward textiles, and digitalDNA®, providing powerful track and trace. All provide a forensic chain of evidence and can be used to prosecute perpetrators.
Forward Looking Statements
The statements made by Applied DNA Sciences may be forward-looking in nature. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in Applied DNA Sciences' SEC reports and filings, including our Annual Report on Form 10-K filed on December 20, 2013 (amended on May 1, 2014) and our subsequent quarterly reports on Form 10-Q/A (for the quarterly period ended December 31, 2013) and Form 10-Q for the quarterly periods ended March 31, 2014 and June 30, 2014. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.